These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6309332)

  • 21. Cross-tolerance studies distinguish morphine- and metkephamid-induced analgesia.
    Hynes MD; Frederickson RC
    Life Sci; 1982 Sep 20-27; 31(12-13):1201-4. PubMed ID: 6292609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
    Porreca F; Burks TF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.
    DeLander GE; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple opiate receptors: phylogenetic differences.
    Buatti MC; Pasternak GW
    Brain Res; 1981 Aug; 218(1-2):400-5. PubMed ID: 6268247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic opioid antagonist treatment: assessment of receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Eur J Pharmacol; 1989 Nov; 170(3):193-200. PubMed ID: 2559854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
    Hong EK; Takemori AE
    J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal and Supraspinal sites for morphine and nefopam analgesia in the mouse.
    Piercey MF; Schroeder LA
    Eur J Pharmacol; 1981 Sep; 74(2-3):135-40. PubMed ID: 6276187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test.
    Porreca F; Mosberg HI; Omnaas JR; Burks TF; Cowan A
    J Pharmacol Exp Ther; 1987 Mar; 240(3):890-4. PubMed ID: 3031278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors.
    Bhargava HN; Pandey RN; Matwyshyn GA
    Life Sci; 1983 May; 32(18):2096-101. PubMed ID: 6133201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meptazinol: a novel Mu-1 selective opioid analgesic.
    Spiegel K; Pasternak GW
    J Pharmacol Exp Ther; 1984 Feb; 228(2):414-9. PubMed ID: 6141283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different receptors mediate morphine-induced prolactin and growth hormone release.
    Spiegel K; Kourides IA; Pasternak GW
    Life Sci; 1982 Nov 15-22; 31(20-21):2177-80. PubMed ID: 6298516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid activity of lefetamine.
    De Montis MG; Devoto P; Bucarelli A; Tagliamonte A
    Pharmacol Res Commun; 1985 May; 17(5):471-8. PubMed ID: 2994123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible mechanisms of morphine analgesia.
    Lipp J
    Clin Neuropharmacol; 1991 Apr; 14(2):131-47. PubMed ID: 1849794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.